Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 1/2 4Phase 3 3Phase NA 2Phase 4 1Phase 1 1

Status

Unknown 3

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Multiple Myeloma 168Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Recurrence 28Leukemia 24Vomiting 23Neoplasms, Plasma Cell 20Lymphoma 18Neoplasms 16Nausea 13Burkitt Lymphoma 11Prostatic Neoplasms 8Immunoglobulin Light-chain Amyloidosis 7Carcinoma, Non-Small-Cell Lung 6Lymphoma, Follicular 5Lung Neoplasms 5Hodgkin Disease 5Ovarian Neoplasms 4Neoplasm Metastasis 4Lymphoma, Non-Hodgkin 4Leukemia, Biphenotypic, Acute 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Small Cell Lung Carcinoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Paraproteinemias 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Fallopian Tube Neoplasms 3

Interventions

Rituximab 28Cyclophosphamide 14ibrutinib 10Vincristine 10Prednisone 10Doxorubicin 10Bendamustine Hydrochloride 9Radiotherapy 7Peripheral Blood Stem Cell Transplantation 6Filgrastim 6zanubrutinib 5acalabrutinib 4Lenalidomide 4Cyclosporine 4orelabrutinib 3Whole-Body Irradiation 3R-CHOP protocol 3Mycophenolic Acid 3Melphalan 3Interferon-alpha 3Etoposide 3Dexamethasone 3Cytarabine 3Cyclosporins 3venetoclax 2liposomal amphotericin B 2fludarabine phosphate 2fludarabine 2VAP-cyclo protocol 2Therapeutics 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Mantle-Cell × Dexamethasone × Clear all
NCT01449344 2017-03-07

(R-HAD)

European Mantle Cell Lymphoma Network

Phase 3 Unknown
128 enrolled
Lymphoid

Recurrence, Lymphoma, Mantle-Cell

NCT00016887 2013-09-17

Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

NCT00209222 2012-09-10

Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL

European Mantle Cell Lymphoma Network

Phase 3 Unknown
360 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡